A US federal judge has struck down part of a Trump administration rule that would have made it harder for some transgender people to access gender-affirming healthcare through Affordable Care Act insurance plans.
Senior US District Judge Nathaniel Gorton ruled that the Department of Health and Human Services had exceeded its authority when it attempted to change which services insurers could classify as “essential health benefits” under the Affordable Care Act, commonly known as Obamacare.
The provision would have prevented certain forms of gender-affirming care from being treated as essential health benefits in non-grandfathered individual and small-group insurance plans.
Gorton vacated that portion of the rule, preventing it from taking effect.
For trans people relying on ACA marketplace insurance, the decision could have a significant impact on both access and affordability.
What The Rule Would Have Changed
The Trump administration’s 2025 Marketplace Integrity And Affordability Final Rule included a provision excluding certain gender-affirming healthcare from the Affordable Care Act’s essential health benefit framework.
That did not mean insurers would have been completely prohibited from covering the care.
Some insurers could still have chosen to cover it, and individual states could still have required coverage under their own laws.
However, removing gender-affirming care from the essential-benefits framework would have stripped that coverage of important protections attached to the Affordable Care Act.
Those protections can affect how insurance subsidies are calculated and how much patients are required to pay out of pocket.
In practical terms, gender-affirming healthcare could have become considerably more expensive or difficult to access for some trans people.
Coalition Of States Challenged The Rule
The case was brought by a coalition of Democratic-led states and Pennsylvania Governor Josh Shapiro.
The plaintiffs challenged several sections of the Trump administration’s rule, arguing that the federal government had exceeded its legal authority and introduced changes that could increase insurance costs and reduce access to healthcare.
Judge Gorton agreed with the states when it came to the gender-affirming-care provision.
He concluded that the Department of Health and Human Services could not simply alter the Affordable Care Act’s categories of essential health benefits in the manner it had attempted.
The administration did, however, successfully defend four other provisions challenged in this portion of the case.
That makes the decision a targeted legal victory rather than a wholesale rejection of the administration’s healthcare rule.
State Officials Welcome The Decision
Officials involved in the case have welcomed the ruling as an important protection for transgender patients.
Massachusetts Attorney General Andrea Joy Campbell described the decision as a major victory for people who rely on gender-affirming healthcare.
She said the provision would have made care more expensive and less accessible for transgender people.
Washington Attorney General Nick Brown similarly accused the federal government of attempting to unlawfully interfere with healthcare coverage residents had been promised under the Affordable Care Act.
For LGBTQ+ advocates, the decision demonstrates the importance of seemingly technical insurance classifications.
Whether a form of healthcare is recognised as an essential health benefit can have real consequences for whether someone can afford treatment.
Gender-Affirming Care Remains A Major Political Target
The court ruling comes amid a much broader campaign by the Trump administration to restrict gender-affirming healthcare across the United States.
Federal agencies have pursued changes affecting insurance coverage, hospital funding and healthcare provided to transgender young people.
The administration has also increasingly used federal funding as leverage against healthcare providers offering gender-affirming treatment.
Just days before Gorton’s ruling, the administration finalised another measure aimed at cutting federal Medicaid and Children’s Health Insurance Program funding connected to certain gender-affirming medical treatments for young people.
Those policies are likely to remain the subject of significant litigation.
The Affordable Care Act decision therefore blocks one route for restricting access, but it does not end the administration’s broader push against transgender healthcare.
Why Essential Health Benefits Matter
The Affordable Care Act requires many individual and small-group health plans to cover 10 broad categories of essential health benefits.
These include areas such as hospital care, prescription medicines, mental-health services, maternity care and preventative services.
The system is designed to stop insurers from selling seemingly affordable policies that exclude major categories of healthcare.
Being included within the essential-benefit framework can also provide protections involving annual or lifetime limits and patient cost-sharing.
For trans people, removing gender-affirming healthcare from that framework could have made access depend much more heavily on where someone lives, which insurer they use and how much they can afford to pay themselves.
That is why the legal fight over what might otherwise sound like a technical insurance rule matters so much.
A Significant Win, But Not The End Of The Fight
The ruling is an important victory for transgender people who rely on Affordable Care Act plans, but the wider legal and political landscape remains uncertain.
The Trump administration continues to pursue multiple avenues aimed at restricting gender-affirming healthcare, particularly for trans young people.
Individual states also remain deeply divided.
Some states have enacted extensive protections for transgender healthcare, while others have introduced restrictions or bans.
That means access can vary dramatically depending on where a person lives.
For LGBTQ+ communities in Aotearoa New Zealand watching developments in the United States, the case is another reminder that healthcare rights can often be shaped through regulatory decisions that receive far less attention than headline legislation.
This particular attempt to make gender-affirming care harder to access through Obamacare has now been stopped.
But for transgender Americans, the broader fight over whether they can access affordable, appropriate healthcare is far from over.
